ConforMIS claims $11m win in patent infringement case against Smith & Nephew

ConforMIS (NSDQ:CFMS) today claimed a win in a patent infringement lawsuit against Smith & Nephew (NYSE:SNN) over technology for patient-specific knee implants.

Bedford, Mass.-based ConforMIS sued the British healthcare giant in 2016 in the U.S. District Court for Massachusetts, alleging infringement of eight patents by Smith & Nephew’s Visionaire cutting guides. Billed as “custom fit,” the Visionaire guides are used with off-the-shelf S&N implants, including the Journey II, Legion, and Genesis II devices.

ConforMIS said the settlement and license agreement calls for the London-based company to pony up $10.5 million and includes a “limited patent cross-license,” resolving all patent litigation between the orthopedic firms.

“We are very pleased to announce the complete settlement of the various patent proceedings we have with Smith & Nephew. Through this settlement, we have once again monetized our patient-specific instrument patents and steadfastly protected our core business of patient-specific implants,” president & CEO Mark Augusti said in prepared remarks.

The post ConforMIS claims $11m win in patent infringement case against Smith & Nephew appeared first on MassDevice.

from MassDevice https://ift.tt/2xsFJtw